{
  "id": 12928756,
  "title": "What's Next for Chronic Hives? New Targets Expand the Treatment Landscape.",
  "url": "https://urgent.news/2026/10/08/whats-next-for-chronic-hives-new-targets-expand-the-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T17:16:52.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/aadfuturefocus/123324"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- New and emerging therapies for chronic spontaneous urticaria (CSU) were a major focus at the American Academy of Dermatology (AAD) meeting, with advances spanning interleukin (IL)-4 receptor blockade, Bruton's tyrosine kinase...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}